Autoinjectors Market by Therapy (Rheumatoid Arthritis, Multiple Sclerosis, Anaphylaxis, Cardiovascular Diseases, Diabetes), Type (Disposable, Reusable), Route of administration (Subcutaneous, Intramuscular), End User (Hospital) - Global Forecast to 2025

Table of Contents

1.... INTRODUCTION

1.1             OBJECTIVES OF THE STUDY
1.2             MARKET DEFINITION & SCOPE
1.3             MARKETS COVERED
・       FIGURE 1..................... AUTOINJECTORS MARKET SEGMENTATION
1.4             YEARS CONSIDERED FOR THE STUDY
1.5             CURRENCY
1.6             LIMITATIONS
1.7             STAKEHOLDERS
1.8             SUMMARY OF CHANGES

2.... RESEARCH METHODOLOGY

2.1             RESEARCH APPROACH
・       FIGURE 2.................................................. RESEARCH DESIGN.. 27
2.1.1              SECONDARY DATA
2.1.1.1            KEY DATA FROM SECONDARY SOURCES
2.1.2              PRIMARY DATA
2.1.2.1            KEY DATA FROM PRIMARY SOURCES
2.1.2.2            BREAKDOWN OF PRIMARIES
・       FIGURE 4. BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE): BY COMPANY TYPE, DESIGNATION, AND REGION
・       FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE): BY END USER, DESIGNATION, AND REGION
2.2             MARKET SIZE ESTIMATION
・       FIGURE 6..... MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS (2019)
・       FIGURE 7..... MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS (2019)
・       FIGURE 8. SUPPLY-SIDE ANALYSIS: AUTOINJECTORS MARKET (2019)
・       FIGURE 9........ CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS OF THE AUTOINJECTORS MARKET (2019)
・       FIGURE 10... CAGR PROJECTIONS FROM THE ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE AUTOINJECTORS MARKET  (2020–2025)
2.3             MARKET BREAKDOWN & DATA TRIANGULATION
2.4             MARKET SHARE ESTIMATION
2.5             ASSUMPTIONS FOR THE STUDY
2.6             COVID-19 HEALTH ASSESSMENT
2.7             COVID-19 ECONOMIC ASSESSMENT
2.8             ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO
・       FIGURE 12................ CRITERIA IMPACTING THE GLOBAL ECONOMY
・       FIGURE 13........... RECOVERY SCENARIO OF THE GLOBAL ECONOMY

3.... EXECUTIVE SUMMARY

・       FIGURE 14... AUTOINJECTORS MARKET, BY THERAPY, 2020 VS. 2025 (USD MILLION)
・       FIGURE 15. AUTOINJECTORS MARKET, BY TYPE, 2020 VS. 2025 (USD MILLION)
・       FIGURE 16....................... AUTOINJECTORS MARKET, BY ROUTE OF ADMINISTRATION, 
2020 VS. 2025 (USD MILLION)
・       FIGURE 17. AUTOINJECTORS MARKET, BY END USER, 2020 VS. 2025 (USD MILLION)
・       FIGURE 18....... GEOGRAPHICAL SNAPSHOT OF THE AUTOINJECTORS MARKET

4.... PREMIUM INSIGHTS

4.1             AUTOINJECTORS MARKET OVERVIEW
・       FIGURE 19... GROWING PREVALENCE OF TARGETED THERAPIES AND RISING PREFERENCE FOR SELF-ADMINISTRATION OF DRUGS TO DRIVE MARKET GROWTH
4.2             ASIA PACIFIC: AUTOINJECTORS MARKET, BY THERAPY AND COUNTRY (2020)
・       FIGURE 20 RHEUMATOID ARTHRITIS SEGMENT TO ACCOUNT FOR THE LARGEST SHARE OF THE APAC MARKET IN 2020
4.3             AUTOINJECTORS MARKET, BY REGION, 2020−2025
・       FIGURE 21....... NORTH AMERICA WILL CONTINUE TO DOMINATE THE AUTOINJECTORS MARKET IN THE FORECAST PERIOD
4.4             AUTOINJECTORS MARKET: DEVELOPED VS. DEVELOPING MARKETS
・       FIGURE 22... DEVELOPING MARKETS TO REGISTER HIGHER GROWTH DURING THE FORECAST PERIOD

5.... MARKET OVERVIEW

5.1             INTRODUCTION
5.2             MARKET DYNAMICS
・       FIGURE 23......... AUTOINJECTORS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES,  & CHALLENGES
5.2.1              DRIVERS
5.2.1.1            GROWING PREVALENCE OF TARGETED THERAPIES
・       FIGURE 24...... CHINA: TOTAL DIABETIC POPULATION FROM 2010 TO 2045
5.2.1.2            RISING INCIDENCE OF ANAPHYLAXIS
5.2.1.3            INCREASING NUMBER OF REGULATORY APPROVALS
・       TABLE 1... RECENT APPROVALS OF AUTOINJECTOR DEVICES ACROSS THE GLOBE
5.2.1.4            AVAILABILITY OF GENERIC VERSIONS OF AUTOINJECTORS
5.2.1.5            FAVORABLE REIMBURSEMENTS AND GOVERNMENT SUPPORT
5.2.1.6            EASE OF USE INCREASING THE PREFERENCE FOR SELF-ADMINISTRATION
5.2.2              RESTRAINTS
5.2.2.1            ALTERNATIVE DRUG DELIVERY MODES
5.2.2.2            RESEARCH, DEVELOPMENT, AND LAUNCH OF ORAL DIABETIC AGENTS AND ORAL INSULIN
5.2.2.3            DEVELOPMENT OF NASAL EPINEPHRINE SPRAYS
5.2.3              OPPORTUNITIES
5.2.3.1            PATENT EXPIRY OF BIOLOGICS TO DRIVE THE DEMAND FOR BIOSIMILARS
・       TABLE 2................................. PATENT EXPIRY OF KEY BIOLOGICS
5.2.3.2            NEED TO LIMIT PATIENT VISITS AND PHYSICAL CONTACT
5.2.4              CHALLENGES
5.2.4.1            DEVELOPMENT OF AUTOINJECTORS FOR MULTIPLE DRUG VISCOSITIES
5.2.4.2            LACK OF PROPER TRAINING FOR USING AUTOINJECTORS
5.3             COVID-19 IMPACT ON THE AUTOINJECTORS MARKET
5.4             AVERAGE SELLING PRICE TRENDS
・       TABLE 3 AVERAGE SELLING PRICE OF EPINEPHRINE AUTOINJECTORS, BY REGION, 2015 VS. 2020
5.5             VALUE CHAIN ANALYSIS
・       FIGURE 25 AUTOINJECTORS MARKET: VALUE CHAIN ANALYSIS (2019)
5.6             ECOSYSTEM ANALYSIS

・       FIGURE 26   ECOSYSTEM: AUTOINJECTORS MARKET (2019)

6.... INDUSTRY INSIGHTS

6.1             INTRODUCTION
6.2             INDUSTRY TRENDS
6.2.1              ADVANCEMENTS IN AUTOINJECTOR DESIGN
6.2.2              WEARABLE AUTOINJECTORS
6.2.3              CONNECTED AUTOINJECTOR DEVICES

7.... AUTOINJECTORS MARKET, BY THERAPY

7.1             INTRODUCTION
・       TABLE 4... AUTOINJECTORS MARKET, BY THERAPY, 2018–2025 (USD MILLION)
7.2             RHEUMATOID ARTHRITIS
7.2.1              INCREASING INCIDENCE OF RA HAS BOOSTED THE ADOPTION OF AUTOINJECTORS
・       TABLE 5.. AUTOINJECTORS MARKET FOR RHEUMATOID ARTHRITIS, BY COUNTRY,  2018–2025 (USD MILLION)
7.3             DIABETES
7.3.1              LARGE PATIENT POPULATION TO STIMULATE THE DEMAND FOR AUTOINJECTORS DURING THE FORECAST PERIOD
・       FIGURE 27... DIABETIC POPULATION: TOP COUNTRIES/TERRITORIES (20–79 YEARS),  2019 VS. 2030 VS. 2045.. 64
・       TABLE 6....... AUTOINJECTORS MARKET FOR DIABETES, BY COUNTRY,
2018–2025 (USD MILLION)
7.4             MULTIPLE SCLEROSIS
7.4.1              INFLUX OF GENERICS IS EXPECTED TO NEGATIVELY IMPACT MARKET GROWTH DURING THE FORECAST PERIOD
・       FIGURE 28....... NUMBER OF PEOPLE WITH MS (PER 100,000) - WHO REGIONS
・       TABLE 7..... AUTOINJECTORS MARKET FOR MULTIPLE SCLEROSIS, BY COUNTRY,
2018–2025 (USD MILLION)
7.5             ANAPHYLAXIS
7.5.1              INCREASING PREVALENCE OF FOOD ALLERGIES TO DRIVE THE UPTAKE OF AUTOINJECTORS
・       TABLE 8.. AUTOINJECTORS MARKET FOR ANAPHYLAXIS, BY COUNTRY,
2018–2025 (USD MILLION)
7.6             OTHER THERAPIES
・       TABLE 9.......... AUTOINJECTORS MARKET FOR OTHER THERAPIES, BY COUNTRY, 
2018–2025 (USD MILLION)
7.7             IMPACT OF COVID-19 ON THE THERAPEUTIC APPLICATIONS OF AUTOINJECTORS

8.... AUTOINJECTORS MARKET, BY TYPE

8.1             INTRODUCTION
・       TABLE 10................... COMPARISON OF DISPOSABLE & REUSABLE AUTOINJECTORS
・       TABLE 11....... AUTOINJECTORS MARKET, BY TYPE, 2018–2025 (USD MILLION)
8.2             DISPOSABLE AUTOINJECTORS
8.2.1              DISPOSABLE AUTOINJECTORS ARE CONVENIENT FOR PATIENTS WITH REDUCED DEXTERITY OR VISUAL IMPAIRMENTS
・       TABLE 12....... DISPOSABLE AUTOINJECTORS MARKET, BY COUNTRY,
2018–2025 (USD MILLION)
8.3             REUSABLE AUTOINJECTORS
8.3.1              REUSABLE AUTOINJECTORS ARE MORE ECONOMICAL AS COMPARED TO DISPOSABLE AUTOINJECTORS
・       TABLE 13.......... REUSABLE AUTOINJECTORS MARKET, BY COUNTRY,
2018–2025 (USD MILLION)

9.... AUTOINJECTORS MARKET, BY ROUTE OF ADMINISTRATION

9.1             INTRODUCTION
・       TABLE 14. AUTOINJECTORS MARKET, BY ROUTE OF ADMINISTRATION,
2018–2025 (USD MILLION)
9.2             SUBCUTANEOUS
9.2.1              GROWING NUMBER OF PRODUCT APPROVALS BY REGULATORY BODIES WILL SUPPORT THE GROWTH OF THIS MARKET SEGMENT
・       TABLE 15.... SUBCUTANEOUS AUTOINJECTORS, BY COUNTRY, 2018–2025 (USD MILLION)
9.3             INTRAMUSCULAR
9.3.1              INTRAMUSCULAR ROUTE OF ADMINISTRATION ENABLES MEDICATION TO BE ABSORBED QUICKLY—A KEY FACTOR DRIVING MARKET GROWTH
・       TABLE 16............ EXAMPLES OF INTRAMUSCULAR AUTOINJECTORS
・       TABLE 17. INTRAMUSCULAR AUTOINJECTORS MARKET, BY COUNTRY,
2018–2025 (USD MILLION)

10.. AUTOINJECTORS MARKET, BY END USER

10.1          INTRODUCTION
・       TABLE 18 AUTOINJECTORS MARKET, BY END USER, 2018–2025 (USD MILLION)
10.2          HOME CARE SETTINGS
10.2.1            HOME CARE THERAPIES ARE COST-EFFECTIVE COMPARED TO TREATMENTS IN HOSPITALS—A KEY FACTOR DRIVING MARKET GROWTH
・       TABLE 19... AUTOINJECTORS MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 
2018–2025 (USD MILLION)
10.3          HOSPITALS & CLINICS
10.3.1            HIGH USAGE OF AUTOINJECTORS IN EMERGENCY CASES IN HOSPITALS & CLINICS WILL DRIVE MARKET GROWTH
・       TABLE 20... AUTOINJECTORS MARKET FOR HOSPITALS & CLINICS, BY COUNTRY,
2018–2025 (USD MILLION)
10.4          AMBULATORY CARE SETTINGS
10.4.1            INCREASING NUMBER OF PATIENTS IN AMBULATORY CARE SETTINGS TO DRIVE THE DEMAND FOR AUTOINJECTORS
・       TABLE 21........... AUTOINJECTORS MARKET FOR AMBULATORY CARE SETTINGS, BY COUNTRY,  2018–2025 (USD MILLION)

11.. AUTOINJECTORS MARKET, BY REGION

11.1          REGIONAL COVID-19 IMPACT: SUMMARY
11.2          INTRODUCTION
・       FIGURE 29.......... AUTOINJECTORS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
・       TABLE 22... AUTOINJECTORS MARKET, BY REGION, 2018–2025 (USD MILLION)
11.3          NORTH AMERICA
・       FIGURE 30... NORTH AMERICA: AUTOINJECTORS MARKET SNAPSHOT
・       TABLE 23. NORTH AMERICA: AUTOINJECTORS MARKET, BY COUNTRY,
2018–2025 (USD MILLION)
・       TABLE 24.. NORTH AMERICA: AUTOINJECTORS MARKET, BY THERAPY,
2018–2025 (USD MILLION)
・       TABLE 25........ NORTH AMERICA: AUTOINJECTORS MARKET, BY TYPE,
2018–2025 (USD MILLION)
・       TABLE 26.. NORTH AMERICA: AUTOINJECTORS MARKET, BY ROUTE OF ADMINISTRATION,  2018–2025 (USD MILLION)
・       TABLE 27 NORTH AMERICA: AUTOINJECTORS MARKET, BY END USER,
2018–2025 (USD MILLION)
11.3.1            US
11.3.1.1          THE US IS THE LARGEST MARKET FOR AUTOINJECTORS IN NORTH AMERICA
・       TABLE 28........ AUTOINJECTORS APPROVED BY THE FDA, 2017-2019
・       TABLE 29... US: AUTOINJECTORS MARKET, BY THERAPY, 2018–2025 (USD MILLION)
・       TABLE 30.. US: AUTOINJECTORS MARKET, BY TYPE, 2018–2025 (USD MILLION). 92
・       TABLE 31.................... US: AUTOINJECTORS MARKET, BY ROUTE OF ADMINISTRATION,
2018–2025 (USD MILLION)
・       TABLE 32.. US: AUTOINJECTORS MARKET, BY END USER, 2018–2025 (USD MILLION)
11.3.2            CANADA
11.3.2.1          RISING PREVALENCE OF CHRONIC DISEASES TO DRIVE THE MARKET GROWTH
・       TABLE 33... CANADA: AUTOINJECTORS MARKET, BY THERAPY, 2018–2025 (USD MILLION)
・       TABLE 34.. CANADA: AUTOINJECTORS MARKET, BY TYPE, 2018–2025 (USD MILLION). 94
・       TABLE 35............ CANADA: AUTOINJECTORS MARKET, BY ROUTE OF ADMINISTRATION, 
2018–2025 (USD MILLION)
・       TABLE 36........... CANADA: AUTOINJECTORS MARKET, BY END USER,
2018–2025 (USD MILLION)
11.4          EUROPE
・       FIGURE 31.............. EUROPE: AUTOINJECTORS MARKET SNAPSHOT
・       TABLE 37............ EUROPE: AUTOINJECTORS MARKET, BY COUNTRY,
2018–2025 (USD MILLION)
・       TABLE 38............. EUROPE: AUTOINJECTORS MARKET, BY THERAPY,
2018–2025 (USD MILLION)
・       TABLE 39.. EUROPE: AUTOINJECTORS MARKET, BY TYPE, 2018–2025 (USD MILLION). 97
・       TABLE 40............. EUROPE: AUTOINJECTORS MARKET, BY ROUTE OF ADMINISTRATION, 
2018–2025 (USD MILLION)
・       TABLE 41........... EUROPE: AUTOINJECTORS MARKET, BY END USER,
2018–2025 (USD MILLION)
11.4.1            GERMANY
11.4.1.1          GERMANY IS THE LARGEST MARKET FOR AUTOINJECTORS IN EUROPE
・       TABLE 42.......... GERMANY: AUTOINJECTORS MARKET, BY THERAPY,
2018–2025 (USD MILLION)
・       TABLE 43 GERMANY: AUTOINJECTORS MARKET, BY TYPE, 2018–2025 (USD MILLION). 99
・       TABLE 44.......... GERMANY: AUTOINJECTORS MARKET, BY ROUTE OF ADMINISTRATION,  2018–2025 (USD MILLION)
・       TABLE 45......... GERMANY: AUTOINJECTORS MARKET, BY END USER,
2018–2025 (USD MILLION)
11.4.2            UK
11.4.2.1          THE UK HAS THE HIGHEST RATE OF ALLERGIC CONDITIONS GLOBALLY—A KEY FACTOR EXPECTED TO BOOST THE MARKET GROWTH
・       TABLE 46... UK: AUTOINJECTORS MARKET, BY THERAPY, 2018–2025 (USD MILLION)
・       TABLE 47.. UK: AUTOINJECTORS MARKET, BY TYPE, 2018–2025 (USD MILLION). 101
・       TABLE 48.................... UK: AUTOINJECTORS MARKET, BY ROUTE OF ADMINISTRATION,
2018–2025 (USD MILLION)
・       TABLE 49.. UK: AUTOINJECTORS MARKET, BY END USER, 2018–2025 (USD MILLION)
11.4.3            FRANCE
11.4.3.1          RISING GERIATRIC POPULATION TO SUPPORT MARKET GROWTH
・       TABLE 50............. FRANCE: AUTOINJECTORS MARKET, BY THERAPY,
2018–2025 (USD MILLION)
・       TABLE 51.. FRANCE: AUTOINJECTORS MARKET, BY TYPE, 2018–2025 (USD MILLION). 103
・       TABLE 52............. FRANCE: AUTOINJECTORS MARKET, BY ROUTE OF ADMINISTRATION, 
2018–2025 (USD MILLION)
・       TABLE 53............ FRANCE: AUTOINJECTORS MARKET, BY END USER,
2018–2025 (USD MILLION)
11.4.4            ITALY
11.4.4.1          IMPROVING ECONOMIC CONDITIONS AND RISING PER CAPITA INCOME TO PROPEL MARKET GROWTH
・       TABLE 54 ITALY: AUTOINJECTORS MARKET, BY THERAPY, 2018–2025 (USD MILLION)
・       TABLE 55...... ITALY: AUTOINJECTORS MARKET, BY TYPE, 2018–2025 (USD MILLION). 104
・       TABLE 56................. ITALY: AUTOINJECTORS MARKET, BY ROUTE OF ADMINISTRATION, 
2018–2025 (USD MILLION)
・       TABLE 57...... ITALY: AUTOINJECTORS MARKET, BY END USER, 2018–2025 (USD MILLION)
11.4.5            SPAIN
11.4.5.1          FAVORABLE REIMBURSEMENT SCENARIO COUPLED WITH THE RISING PREVALENCE OF CHRONIC DISEASES TO SUPPORT MARKET GROWTH
・       TABLE 58 SPAIN: AUTOINJECTORS MARKET, BY THERAPY, 2018–2025 (USD MILLION)
・       TABLE 59..... SPAIN: AUTOINJECTORS MARKET, BY TYPE, 2018–2025 (USD MILLION). 106
・       TABLE 60............... SPAIN: AUTOINJECTORS MARKET, BY ROUTE OF ADMINISTRATION, 
2018–2025 (USD MILLION)
・       TABLE 61..... SPAIN: AUTOINJECTORS MARKET, BY END USER, 2018–2025 (USD MILLION)
11.4.6            REST OF EUROPE
・       TABLE 62. ROE: AUTOINJECTORS MARKET, BY THERAPY, 2018–2025 (USD MILLION)
・       TABLE 63 ROE: AUTOINJECTORS MARKET, BY TYPE, 2018–2025 (USD MILLION). 108
・       TABLE 64.................. ROE: AUTOINJECTORS MARKET, BY ROUTE OF ADMINISTRATION,
2018–2025 (USD MILLION)

・       TABLE 65 ROE: AUTOINJECTORS MARKET, BY END USER, 2018–2025 (USD MILLION)
11.5          ASIA PACIFIC
・       FIGURE 32....... ASIA PACIFIC: AUTOINJECTORS MARKET SNAPSHOT
・       TABLE 66...... ASIA PACIFIC: AUTOINJECTORS MARKET, BY COUNTRY,
2018–2025 (USD MILLION)
・       TABLE 67...... ASIA PACIFIC: AUTOINJECTORS MARKET, BY THERAPY,
 2018–2025 (USD MILLION)
・       TABLE 68............ ASIA PACIFIC: AUTOINJECTORS MARKET, BY TYPE,
 2018–2025 (USD MILLION)
・       TABLE 69...... ASIA PACIFIC: AUTOINJECTORS MARKET, BY ROUTE OF ADMINISTRATION,  2018–2025 (USD MILLION)
・       TABLE 70..... ASIA PACIFIC: AUTOINJECTORS MARKET, BY END USER,
 2018–2025 (USD MILLION)
11.5.1            JAPAN
11.5.1.1          HIGH ADOPTION OF AUTOINJECTORS AND APPROVAL OF SEVERAL INJEC・       TABLE DEVICES TO BOOST THE MARKET GROWTH
・       TABLE 71...... JAPAN: AUTOINJECTORS MARKET, BY THERAPY, 2018–2025 (USD MILLION)
・       TABLE 72.... JAPAN: AUTOINJECTORS MARKET, BY TYPE, 2018–2025 (USD MILLION). 113
・       TABLE 73............... JAPAN: AUTOINJECTORS MARKET, BY ROUTE OF ADMINISTRATION,
 2018–2025 (USD MILLION)
・       TABLE 74.... JAPAN: AUTOINJECTORS MARKET, BY END USER, 2018–2025 (USD MILLION)
11.5.2            CHINA
11.5.2.1          FOOD ALLERGIES AND ANAPHYLAXIS HAVE BECOME A MAJOR PUBLIC HEALTH BURDEN IN CHINA
・       TABLE 75...... CHINA: AUTOINJECTORS MARKET, BY THERAPY, 2018–2025 (USD MILLION)
・       TABLE 76.... CHINA: AUTOINJECTORS MARKET, BY TYPE, 2018–2025 (USD MILLION). 115
・       TABLE 77............... CHINA: AUTOINJECTORS MARKET, BY ROUTE OF ADMINISTRATION,
 2018–2025 (USD MILLION)
・       TABLE 78.... CHINA: AUTOINJECTORS MARKET, BY END USER, 2018–2025 (USD MILLION)
11.5.3            INDIA
11.5.3.1          INCREASING BURDEN OF CHRONIC DISEASES SUCH AS DIABETES AND CVD IS EXPECTED TO DRIVE THE DEMAND FOR AUTOINJECTORS IN INDIA.. 116
・       TABLE 79 INDIA: AUTOINJECTORS MARKET, BY THERAPY, 2018–2025 (USD MILLION)
・       TABLE 80..... INDIA: AUTOINJECTORS MARKET, BY TYPE, 2018–2025 (USD MILLION). 117
・       TABLE 81................ INDIA: AUTOINJECTORS MARKET, BY ROUTE OF ADMINISTRATION, 
2018–2025 (USD MILLION)
・       TABLE 82..... INDIA: AUTOINJECTORS MARKET, BY END USER, 2018–2025 (USD MILLION)
11.5.4            ROAPAC
・       TABLE 83............. ROAPAC: AUTOINJECTORS MARKET, BY THERAPY,
2018–2025 (USD MILLION)
・       TABLE 84.. ROAPAC: AUTOINJECTORS MARKET, BY TYPE, 2018–2025 (USD MILLION). 119
・       TABLE 85............ ROAPAC: AUTOINJECTORS MARKET, BY ROUTE OF ADMINISTRATION,
  2018–2025 (USD MILLION)
・       TABLE 86........... ROAPAC: AUTOINJECTORS MARKET, BY END USER,
2018–2025 (USD MILLION)
11.6          LATIN AMERICA
11.6.1            RISING ELDERLY POPULATION IN COUNTRIES SUCH AS BRAZIL AND MEXICO TO SUPPORT MARKET GROWTH
・       TABLE 87... LATIN AMERICA: AUTOINJECTORS MARKET, BY THERAPY,
2018–2025 (USD MILLION)
・       TABLE 88......... LATIN AMERICA: AUTOINJECTORS MARKET, BY TYPE,
2018–2025 (USD MILLION)
・       TABLE 89... LATIN AMERICA: AUTOINJECTORS MARKET, BY ROUTE OF ADMINISTRATION,  2018–2025 (USD MILLION)
・       TABLE 90.. LATIN AMERICA: AUTOINJECTORS MARKET, BY END USER,
2018–2025 (USD MILLION)
11.7          MIDDLE EAST & AFRICA
11.7.1            IMPLEMENTATION OF FAVORABLE REFORMS IN AFRICA AS WELL AS MIDDLE EASTERN COUNTRIES TO DRIVE MARKET GROWTH
・       TABLE 91. MEA: AUTOINJECTORS MARKET, BY THERAPY, 2018–2025 (USD MILLION)
・       TABLE 92 MEA: AUTOINJECTORS MARKET, BY TYPE, 2018–2025 (USD MILLION). 123
・       TABLE 93................. MEA: AUTOINJECTORS MARKET, BY ROUTE OF ADMINISTRATION,
 2018–2025 (USD MILLION)
・       TABLE 94 MEA: AUTOINJECTORS MARKET, BY END USER, 2018–2025 (USD MILLION)

12.. COMPANY EVALUATION MATRIX

12.1          MARKET SHARE ANALYSIS
・       FIGURE 33........ AUTOINJECTORS MARKET SHARE ANALYSIS, BY KEY PLAYER, 2019
12.2          VENDOR DIVE
12.2.1            STARS
12.2.2            EMERGING LEADERS
12.2.3            PERVASIVE PLAYERS
12.2.4            EMERGING COMPANIES
・       FIGURE 34..... AUTOINJECTORS MARKET: COMPETITIVE LEADERSHIP MAPPING, 2019
12.3          COMPETITIVE LEADERSHIP MAPPING FOR SMALL & MEDIUM-SIZED ENTERPRISES (SMES)/STARTUPS
12.3.1            PROGRESSIVE COMPANIES
12.3.2            STARTING BLOCKS
12.3.3            RESPONSIVE COMPANIES
12.3.4            DYNAMIC COMPANIES
・       FIGURE 35..... AUTOINJECTORS MARKET: COMPETITIVE LEADERSHIP MAPPING FOR START-UPS, 2019

13.. COMPETITIVE LANDSCAPE

13.1          INTRODUCTION
・       FIGURE 36..... KEY DEVELOPMENTS IN THE AUTOINJECTORS MARKET
・       FIGURE 37...................................... GROWTH STRATEGY MATRIX
13.2          PRODUCT PORTFOLIO MATRIX
13.2.1            THERAPY
13.3          AUTOINJECTORS MARKET: GEOGRAPHICAL ASSESSMENT
・       FIGURE 38....... GEOGRAPHIC ASSESSMENT OF KEY PLAYERS IN THE AUTOINJECTORS MARKET (2019)
13.4          AUTOINJECTORS MARKET: R&D EXPENDITURE
・       FIGURE 39.................. R&D EXPENDITURE OF KEY PLAYERS IN THE AUTOINJECTORS MARKET (2019)
13.5          COMPETITIVE SITUATIONS AND TRENDS
13.5.1            PRODUCT LAUNCHES & APPROVALS
・       TABLE 95.......... PRODUCT LAUNCHES & APPROVALS (2018–2020)
13.5.2            PARTNERSHIPS, COLLABORATIONS, AND AGREEMENTS
・       TABLE 96.... PARTNERSHIPS, COLLABORATIONS, AND AGREEMENTS (2018–2020)
13.5.3            ACQUISITIONS
・       TABLE 97............................................... ACQUISITIONS (2020)
13.5.4            EXPANSIONS
・       TABLE 98........................................ EXPANSIONS (2018–2020)
13.5.5            OTHER DEVELOPMENTS
・       TABLE 99........................... OTHER DEVELOPMENTS (2019–2020)

14.. COMPANY PROFILES

(BUSINESS OVERVIEW, PRODUCTS OFFERED, RECENT DEVELOPMENTS, MNM VIEW, AND STRATEGIC OVERVIEW)*
14.1          ABBVIE INC.
・       FIGURE 40................... ABBVIE INC.: COMPANY SNAPSHOT (2019)
14.2          AMGEN
・       FIGURE 41......................... AMGEN: COMPANY SNAPSHOT (2019)
14.3          ELI LILLY AND COMPANY
・       FIGURE 42... ELI LILLY AND COMPANY: COMPANY SNAPSHOT (2019)
14.4          MYLAN
・       FIGURE 43......................... MYLAN: COMPANY SNAPSHOT (2019)
14.5          YPSOMED
・       FIGURE 44..................... YPSOMED: COMPANY SNAPSHOT (2019)
14.6          BECTON, DICKINSON AND COMPANY
・       FIGURE 45.............................. BD: COMPANY SNAPSHOT (2019). 149

14.7          GLAXOSMITHKLINE PLC
・       FIGURE 46.... GLAXOSMITHKLINE PLC: COMPANY SNAPSHOT (2019)
14.8          JOHNSON & JOHNSON (J&J)
・       FIGURE 47...... JOHNSON & JOHNSON: COMPANY SNAPSHOT (2019)
14.9          TEVA PHARMACEUTICAL INDUSTRIES
・       FIGURE 48........... TEVA PHARMACEUTICAL INDUSTRIES: COMPANY SNAPSHOT (2019)
14.10        ANTARES PHARMA, INC.
・       FIGURE 49.......... ANTARES PHARMA: COMPANY SNAPSHOT (2019)
14.11        MERCK KGAA
・       FIGURE 50................. MERCK KGAA: COMPANY SNAPSHOT (2019)
14.12        MERIDIAN MEDICAL TECHNOLOGIES, INC. (A PFIZER COMPANY)
・       FIGURE 51......................... PFIZER: COMPANY SNAPSHOT (2019)
14.13        F. HOFFMANN-LA ROCHE
・       FIGURE 52...... F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT (2019)
14.14        BESPAK
・       FIGURE 53... CONSORT MEDICAL PLC: COMPANY SNAPSHOT (2019)
14.15        BAYER AG
・       FIGURE 54..................... BAYER AG: COMPANY SNAPSHOT (2019)
14.16        BRISTOL-MYERS SQUIBB COMPANY
・       FIGURE 55............. BRISTOL-MYERS SQUIBB COMPANY: COMPANY SNAPSHOT (2019)
14.17        SHL MEDICAL
14.18        HASELMEIER
14.19        OWEN MUMFORD
14.20        RAVIMED
14.21        MEDECA PHARMA AB
*DETAILS ON BUSINESS OVERVIEW, PRODUCTS OFFERED, RECENT DEVELOPMENTS, MNM VIEW, AND STRATEGIC OVERVIEW MIGHT NOT BE CAPTURED IN CASE OF UNLISTED COMPANIES.
15.. APPENDIX

当レポートのプレスリリースは発行されておりません。